NMRD Stock Chart & Stats
$0.05
$0.00(0.00%)
At close: 4:00 PM EST
$0.05
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.39
Previous CloseN/A
Volume1.50K
Average Volume (3M)8.94K
Market Cap
$4.04K
Enterprise Value$25.83
Total Cash (Recent Filing)$137.42K
Total Debt (Recent Filing)$19.64M
Price to Earnings (P/E)―
Beta-190.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,351,704
10 Day Avg. Volume8,942
30 Day Avg. Volume8,942
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)-1.88
Price to Sales (P/S)289.00
P/FCF Ratio-2.48
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nemaura Medical News
NMRD FAQ
What was Nemaura Medical Inc’s price range in the past 12 months?
Nemaura Medical Inc lowest stock price was $0.01 and its highest was $0.39 in the past 12 months.
What is Nemaura Medical Inc’s market cap?
Nemaura Medical Inc’s market cap is $4.04K.
When is Nemaura Medical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nemaura Medical Inc’s earnings last quarter?
Currently, no data Available
Is Nemaura Medical Inc overvalued?
According to Wall Street analysts Nemaura Medical Inc’s price is currently Overvalued.
Does Nemaura Medical Inc pay dividends?
Nemaura Medical Inc does not currently pay dividends.
What is Nemaura Medical Inc’s EPS estimate?
Nemaura Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nemaura Medical Inc have?
Nemaura Medical Inc has 40,351,704 shares outstanding.
What happened to Nemaura Medical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nemaura Medical Inc?
Currently, no hedge funds are holding shares in NMRD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nemaura Medical Inc
Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invasive continuous glucose monitoring (CGM) system. This device is designed to assist individuals with Type 1 and Type 2 diabetes in managing their condition, and it can also screen for pre-diabetic states. Beyond this, Nemaura offers proBEAT, a wellness guidance service that delivers educational prompts to users about factors influencing their blood sugar profiles. The company also conducts specialized programs aimed at diabetes prevention and reversal. Established in 2009, Nemaura Medical Inc. operates from its headquarters in New York City.
Technical Analysis
Dexcom
―
Insulet
―
Tandem Diabetes Care
―
Xtant Medical Holdings
―
Senseonics Holdings
―
Ownership Overview
―
Insiders
―
Mutual Funds
2.09% Other Institutional Investors
97.91% Public Companies and
Individual Investors